Chronic intestinal pseudoobstruction (CIPO) is a serious complication in patients with connective tissue disease (CTD) and is sometimes life-threatening or fatal despite intensive medical treatment. Here, we report a patient with dermatomyositis (DM) and anti-EJ autoantibody who developed CIPO that was improved by octreotide. Because her abdominal pain and bloatedness were so severe and persistent, we introduced octreotide to relieve symptoms. In this case, continuous intravenous administration as well as long-acting subcutaneous injection of octreotide was effective for treating CIPO.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5112325 | PMC |
http://dx.doi.org/10.1155/2016/9510316 | DOI Listing |
Diagnostics (Basel)
September 2024
Rheumatology and Clinical Immunology Unit, ERN ReCONNET Centre, ASST Spedali Civili, Piazzale Spedali Civili, 1, 25124 Brescia, Italy.
Int J Rheumatol
September 2024
Department of Rheumatology and Immunology The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi Province 530021, China.
J Clin Rheumatol
October 2024
Department of Pediatrics.
Cureus
April 2024
Rheumatology, Toho University Sakura Medical Center, Sakura-shi, JPN.
Coronavirus disease 2019 (COVID-19) is a life-threatening respiratory disease characterized by severe acute infection. In some cases, COVID-19 symptoms may persist for a long term, posing a significant social problem. Long-term COVID-19 symptoms resemble those observed in various autoimmune diseases, such as dermatomyositis and polymyositis.
View Article and Find Full Text PDFSarcoidosis Vasc Diffuse Lung Dis
March 2024
Department of Respiratory Medicine and Rheumatology,Graduate School of Biomedical Sciences, Tokushima University.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!